Investigators provide recent information on the classification, pathophysiology, diagnosis, and treatment of pulmonary arterial hypertension, focusing specifically on its impact on women. Pulmonary ...
Hyperuricemia may causally contribute to PAH, positioning uric acid as a potential therapeutic target for treatment and prevention. Mendelian randomization analysis suggests a genetic-level causal ...
Both genera and regional anesthesia can be safely used in patients with pulmonary arterial hypertension (PAH). PAH has an incidence of 15 to 50 cases per 1 million adults, and it is more common among ...
Pulmonary hypertension is characterized by increased BP in the pulmonary vasculature You will want your patients to consult a specialist to slow progression of this debilitating disease. Here's what ...
Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...
A new phase 3 study comparing mono and duo therapies may yield greater guidance and treatment options for children with pulmonary arterial hypertension (PAH). PAH is a rare condition in children, but ...
Scientists in China used computer analyses to identify two genes driving pulmonary arterial hypertension that may prove a ...
Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries that go from your heart to your lungs. It happens when these arteries become narrow or blocked, making it harder ...
Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries in your lungs. It happens when these arteries become narrow or blocked, making it harder for blood to flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results